Brian C. Thomas
Chief Executive Officer at Metagenomi Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2024
3 years of board service in total across 1 board, counting each seat separately. Longest: Metagenomi Therapeutics Inc., 2 years.
Metagenomi Therapeutics Inc.
Director · Chief Executive Officer
Chief executive roles
Metagenomi Therapeutics Inc.
· Chief Executive Officer
Since February 2024
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Dec 5, 2025 | Metagenomi Therapeutics Inc. | Open-market sale | −3,830 | $1.77 | $6,779 |
| Sep 5, 2025 | Metagenomi Therapeutics Inc. | Open-market sale | −2,701 | $1.81 | $4,889 |
| Jun 6, 2025 | Metagenomi Therapeutics Inc. | Open-market sale | −10,785 | $1.75 | $18,874 |
| Apr 1, 2025 | Metagenomi Therapeutics Inc. | Grant or award | +32,000 | — | — |
| Apr 1, 2024 | Metagenomi Therapeutics Inc. | Grant or award | +118,992 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.